Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.
- DOI
- 10.1158/1541-7786.mcr-10-0141
- Published
- 2010 Oct
- Container
- Molecular cancer research : MCR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1541-7786.mcr-10-0141,
title = {Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.},
author = {Reuter S and Prasad S and Phromnoi K and Kannappan R and Yadav VR and Aggarwal BB},
year = {2010},
journal = {Molecular cancer research : MCR},
doi = {10.1158/1541-7786.mcr-10-0141},
url = {https://doi.org/10.1158/1541-7786.mcr-10-0141}
}RIS
TY - JOUR TI - Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway. AU - Reuter S AU - Prasad S AU - Phromnoi K AU - Kannappan R AU - Yadav VR AU - Aggarwal BB PY - 2010 JO - Molecular cancer research : MCR DO - 10.1158/1541-7786.mcr-10-0141 UR - https://doi.org/10.1158/1541-7786.mcr-10-0141 ER -
APA
S, R., S, P., K, P., R, K., VR, Y., & BB, A. (2010). Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway.. Molecular cancer research : MCR. https://doi.org/10.1158/1541-7786.mcr-10-0141
Source records
- pubmed · retrieved 2026-09-26T03:59:51.585Z